{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T06:37:35Z","timestamp":1775025455592,"version":"3.50.1"},"reference-count":56,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2013,1,1]],"date-time":"2013-01-01T00:00:00Z","timestamp":1356998400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Progress in Cardiovascular Diseases"],"published-print":{"date-parts":[[2013,1]]},"DOI":"10.1016\/j.pcad.2012.11.007","type":"journal-article","created":{"date-parts":[[2013,3,15]],"date-time":"2013-03-15T19:49:51Z","timestamp":1363376991000},"page":"396-401","source":"Crossref","is-referenced-by-count":3,"title":["Overview of the Contribution of Recent Clinical Trials to Advancement of Syncope Management"],"prefix":"10.1016","volume":"55","author":[{"given":"Angel","family":"Moya","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nuria","family":"Rivas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jordi","family":"Perez-Rodon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.pcad.2012.11.007_bb0005","doi-asserted-by":"crossref","first-page":"2631","DOI":"10.1093\/eurheartj\/ehp298","article-title":"Guidelines for the diagnosis and management of syncope (version 2009)","volume":"30","author":"Moya","year":"2009","journal-title":"Eur Heart J"},{"key":"10.1016\/j.pcad.2012.11.007_bb0010","doi-asserted-by":"crossref","first-page":"40","DOI":"10.3399\/bjgp11X548965","article-title":"NICE guideline: transient loss of consciousness (blackouts) in adults and young people","volume":"61","author":"Rogers","year":"2011","journal-title":"Br J Gen Pract"},{"key":"10.1016\/j.pcad.2012.11.007_bb0015","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.cjca.2010.11.002","article-title":"Standardized approaches to the investigation of syncope: Canadian Cardiovascular Society position paper","volume":"27","author":"Sheldon","year":"2011","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.pcad.2012.11.007_bb0020","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1016\/S0002-9149(97)89158-8","article-title":"Recurrence of neurocardiogenic syncope without pharmacologic interventions","volume":"77","author":"Natale","year":"1996","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.pcad.2012.11.007_bb0025","doi-asserted-by":"crossref","first-page":"R40","DOI":"10.1152\/ajpregu.00544.2010","article-title":"The osmopressor response to water drinking","volume":"300","author":"May","year":"2011","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"10.1016\/j.pcad.2012.11.007_bb0030","doi-asserted-by":"crossref","first-page":"2806","DOI":"10.1161\/01.CIR.0000038921.64575.D0","article-title":"Water drinking acutely improves orthostatic tolerance in healthy subjects","volume":"106","author":"Schroeder","year":"2002","journal-title":"Circulation"},{"issue":"Suppl. 1","key":"10.1016\/j.pcad.2012.11.007_bb0035","doi-asserted-by":"crossref","first-page":"I\/62","DOI":"10.1007\/s10286-004-1009-x","article-title":"Nonpharmacological treatment of reflex syncope","volume":"14","author":"Wieling","year":"2004","journal-title":"Clin Auton Res"},{"key":"10.1016\/j.pcad.2012.11.007_bb0040","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1016\/j.amjcard.2008.06.019","article-title":"Vasodilation in vasovagal syncope and the effect of water ingestion","volume":"102","author":"Flevari","year":"2008","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.pcad.2012.11.007_bb0045","doi-asserted-by":"crossref","first-page":"2053","DOI":"10.1016\/S0735-1097(02)02683-9","article-title":"Isometric arm counter-pressure maneuvers to abort impending vasovagal syncope","volume":"40","author":"Brignole","year":"2002","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.pcad.2012.11.007_bb0050","doi-asserted-by":"crossref","first-page":"1684","DOI":"10.1161\/01.CIR.0000030939.12646.8F","article-title":"Management of vasovagal syncope: controlling or aborting faints by leg crossing and muscle tensing","volume":"106","author":"Krediet","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.pcad.2012.11.007_bb0055","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.eupc.2004.03.008","article-title":"Efficacy and feasibility of isometric arm counter-pressure manoeuvres to abort impending vasovagal syncope during real life","volume":"6","author":"Croci","year":"2004","journal-title":"Europace"},{"key":"10.1016\/j.pcad.2012.11.007_bb0060","doi-asserted-by":"crossref","first-page":"1652","DOI":"10.1016\/j.jacc.2006.06.059","article-title":"Effectiveness of physical counterpressure maneuvers in preventing vasovagal syncope: the Physical Counterpressure Manoeuvres Trial (PC-Trial)","volume":"48","author":"van Dijk","year":"2006","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.pcad.2012.11.007_bb0065","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1111\/j.1540-8159.1998.tb01087.x","article-title":"Tilt training: a new treatment for recurrent neurocardiogenic syncope and severe orthostatic intolerance","volume":"2","author":"Ector","year":"1998","journal-title":"Pacing Clin Electrophysiol"},{"key":"10.1016\/j.pcad.2012.11.007_bb0070","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.eupc.2004.01.002","article-title":"Efficacy of tilt training in the treatment of neurally mediated syncope. A randomized study","volume":"6","author":"Foglia-Manzillo","year":"2004","journal-title":"Europace"},{"key":"10.1016\/j.pcad.2012.11.007_bb0075","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1111\/j.1540-8159.2007.00725.x","article-title":"Is home orthostatic self-training effective in preventing neurocardiogenic syncope? A prospective and randomized study","volume":"30","author":"On","year":"2007","journal-title":"Pacing Clin Electrophysiolo"},{"key":"10.1016\/j.pcad.2012.11.007_bb0080","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1111\/j.1540-8159.2007.00898.x","article-title":"Tilt training: does it have a role in preventing vasovagal syncope?","volume":"30","author":"Gurevitz","year":"2007","journal-title":"Pacing Clin Electrophysiol"},{"key":"10.1016\/j.pcad.2012.11.007_bb0085","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1093\/europace\/eup368","article-title":"Home orthostatic training in vasovagal syncope modifies autonomic tone: results of a randomized, placebo-controlled pilot study","volume":"12","author":"Tan","year":"2010","journal-title":"Europacen"},{"key":"10.1016\/j.pcad.2012.11.007_bb0090","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1016\/S0002-9149(96)00342-6","article-title":"Usefulness of transdermal scopolamine for vasovagal syncope","volume":"78","author":"Lee","year":"1996","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.pcad.2012.11.007_bb0095","doi-asserted-by":"crossref","first-page":"1843","DOI":"10.1016\/0735-1097(93)90767-U","article-title":"A placebo-controlled trial of intravenous and oral disopyramide for prevention of neurally mediated syncope induced by head-up tilt","volume":"22","author":"Morillo","year":"1993","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.pcad.2012.11.007_bb0100","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1136\/hrt.77.3.268","article-title":"Malignant vasovagal syncope: a randomised trial of metoprolol and clonidine","volume":"77","author":"Biffi","year":"1997","journal-title":"Heart"},{"key":"10.1016\/j.pcad.2012.11.007_bb0105","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1016\/j.jacc.2004.11.033","article-title":"Effectiveness of fludrocortisone and salt in preventing syncope recurrence in children: a double-blind, placebo-controlled, randomized trial","volume":"45","author":"Salim","year":"2005","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.pcad.2012.11.007_bb0110","doi-asserted-by":"crossref","first-page":"1186.e11","DOI":"10.1016\/j.ahj.2006.03.013","article-title":"The Second Prevention of Syncope Trial (POST II)\u2014a randomized clinical trial of fludrocortisone for the prevention of neurally mediated syncope: rationale and study design","volume":"151","author":"Raj","year":"2006","journal-title":"Am Heart J"},{"key":"10.1016\/j.pcad.2012.11.007_bb0115","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1046\/j.1460-9592.2002.t01-1-00816.x","article-title":"A randomized and controlled pilot trial of beta-blockers for the treatment of recurrent syncope in patients with a positive or negative response to head-up tilt test","volume":"25","author":"Ventura","year":"2002","journal-title":"Pacing Clin Electrophysiol"},{"key":"10.1016\/j.pcad.2012.11.007_bb0120","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1016\/S0735-1097(00)01155-4","article-title":"Lack of efficacy of atenolol for the prevention of neurally mediated syncope in a highly symptomatic population: a prospective, double-blind, randomized and placebo-controlled study","volume":"37","author":"Madrid","year":"2001","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.pcad.2012.11.007_bb0125","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/S0735-1097(02)01974-5","article-title":"Vasovagal syncope: a prospective, randomized, crossover evaluation of the effect of propranolol, nadolol and placebo on syncope recurrence and patients well-being","volume":"40","author":"Flevari","year":"2002","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.pcad.2012.11.007_bb0130","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1161\/CIRCULATIONAHA.105.535161","article-title":"Prevention of Syncope Trial (POST): a randomized, placebo-controlled study of metoprolol in the prevention of vasovagal syncope","volume":"113","author":"Sheldon","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.pcad.2012.11.007_bb0135","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1111\/j.1540-8167.2009.01518.x","article-title":"Effect of metoprolol on quality of life in the Prevention of Syncope Trial","volume":"20","author":"Sheldon","year":"2009","journal-title":"J Cardiovasc Electrophysiol"},{"key":"10.1016\/j.pcad.2012.11.007_bb0140","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/S0002-9149(00)00972-3","article-title":"Effects of intravenous etilefrine in neurocardiogenic syncope induced by head-up tilt testing","volume":"86","author":"Ammirati","year":"2000","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.pcad.2012.11.007_bb0145","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/0735-1097(94)00336-O","article-title":"Limitations of head-up tilt test for evaluating the efficacy of therapeutic interventions in patients with vasovagal syncope: results of a controlled study of etilefrine versus placebo","volume":"25","author":"Moya","year":"1995","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.pcad.2012.11.007_bb0150","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1161\/01.CIR.99.11.1452","article-title":"Effect of etilefrine in preventing syncopal recurrence in patients with vasovagal syncope: a double-blind, randomized, placebo-controlled trial. The Vasovagal Syncope International Study","volume":"99","author":"Raviele","year":"1999","journal-title":"Circulation"},{"key":"10.1016\/j.pcad.2012.11.007_bb0155","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1023\/A:1009813312936","article-title":"Preliminary observations on the use of midodrine hydrochloride in the treatment of refractory neurocardiogenic syncope","volume":"3","author":"Grubb","year":"1999","journal-title":"J Interv Card Electrophysiol"},{"key":"10.1016\/j.pcad.2012.11.007_bb0160","doi-asserted-by":"crossref","first-page":"1620","DOI":"10.1111\/j.1540-8159.1999.tb00381.x","article-title":"Midodrine hydrochloride in the treatment of vasovagal syncope","volume":"22","author":"Mitro","year":"1999","journal-title":"Pacing Clin Electrophysiol"},{"issue":"A7","key":"10.1016\/j.pcad.2012.11.007_bb0165","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/S0002-9149(01)01594-6","article-title":"Efficacy and safety of midodrine hydrochloride in patients with refractory vasovagal syncope","volume":"88","author":"Samniah","year":"2001","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.pcad.2012.11.007_bb0170","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1046\/j.1540-8167.2001.00935.x","article-title":"Usefulness of midodrine in patients with severely symptomatic neurocardiogenic syncope: a randomized control study","volume":"12","author":"Perez-Lugones","year":"2001","journal-title":"J Cardiovasc Electrophysiol"},{"key":"10.1016\/j.pcad.2012.11.007_bb0175","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1016\/j.jpeds.2006.07.031","article-title":"The efficacy of midodrine hydrochloride in the treatment of children with vasovagal syncope","volume":"149","author":"Qingyou","year":"2006","journal-title":"J Pediatr"},{"key":"10.1016\/j.pcad.2012.11.007_bb0180","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1093\/europace\/eur200","article-title":"Effectiveness of midodrine treatment in patients with recurrent vasovagal syncope not responding to non-pharmacological treatment (STAND-trial)","volume":"13","author":"Romme","year":"2011","journal-title":"Europace"},{"key":"10.1016\/j.pcad.2012.11.007_bb0185","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1016\/S0735-1097(98)00694-9","article-title":"Effects of paroxetine hydrochloride, a selective serotonin reuptake inhibitor, on refractory vasovagal syncope: a randomized, double-blind, placebo-controlled study","volume":"33","author":"Di Girolamo","year":"1999","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.pcad.2012.11.007_bb0190","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1093\/europace\/euj041","article-title":"Fluoxetine vs. propranolol in the treatment of vasovagal syncope: a prospective, randomized, placebo-controlled study","volume":"8","author":"Theodorakis","year":"2006","journal-title":"Europace"},{"key":"10.1016\/j.pcad.2012.11.007_bb0195","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/S0735-1097(98)00549-X","article-title":"The North American Vasovagal Pacemaker Study (VPS). A randomized trial of permanent cardiac pacing for the prevention of vasovagal syncope","volume":"33","author":"Connolly","year":"1999","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.pcad.2012.11.007_bb0200","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1161\/01.CIR.102.3.294","article-title":"Dual-chamber pacing in the treatment of neurally mediated tilt-positive cardioinhibitory syncope: pacemaker versus no therapy: a multicenter randomized study. The Vasovagal Syncope International Study (VASIS) Investigators","volume":"102","author":"Sutton","year":"2000","journal-title":"Circulation"},{"key":"10.1016\/j.pcad.2012.11.007_bb0205","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1161\/hc2601.091708","article-title":"Syncope Diagnosis and Treatment Study Investigators. Permanent cardiac pacing versus medical treatment for the prevention of recurrent vasovagal syncope: a multicenter, randomized, controlled trial","volume":"104","author":"Ammirati","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.pcad.2012.11.007_bb0210","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1016\/j.eupc.2004.08.009","article-title":"Closed loop stimulation in prevention of vasovagal syncope. Inotropy Controlled Pacing in Vasovagal Syncope (INVASY): a multicentre randomized, single blind, controlled study","volume":"6","author":"Occhetta","year":"2004","journal-title":"Europace"},{"key":"10.1016\/j.pcad.2012.11.007_bb0215","doi-asserted-by":"crossref","first-page":"2224","DOI":"10.1001\/jama.289.17.2224","article-title":"Pacemaker therapy for prevention of syncope in patients with recurrent severe vasovagal syncope: Second Vasovagal Pacemaker Study (VPS II): a randomized trial","volume":"289","author":"Connolly","year":"2003","journal-title":"JAMA"},{"key":"10.1016\/j.pcad.2012.11.007_bb0220","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1016\/j.ehj.2004.06.031","article-title":"A randomized, double-blind, placebo-controlled study of permanent cardiac pacing for the treatment of recurrent tilt-induced vasovagal syncope. The vasovagal syncope and pacing trial (SYNPACE)","volume":"25","author":"Raviele","year":"2004","journal-title":"Eur Heart J"},{"key":"10.1016\/j.pcad.2012.11.007_bb0225","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.amjmed.2006.05.046","article-title":"The expectation effect and cardiac pacing for refractory vasovagal syncope","volume":"120","author":"Sud","year":"2007","journal-title":"Am J Med"},{"key":"10.1016\/j.pcad.2012.11.007_bb0230","doi-asserted-by":"crossref","first-page":"2232","DOI":"10.1093\/eurheartj\/ehl164","article-title":"International Study on Syncope of Uncertain Etiology 2 (ISSUE 2) Group. Lack of correlation between the responses to tilt testing and adenosine triphosphate test and the mechanism of spontaneous neurally mediated syncope","volume":"27","author":"Brignole","year":"2006","journal-title":"Eur Heart J"},{"key":"10.1016\/j.pcad.2012.11.007_bb0235","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1161\/hc3601.095708","article-title":"International Study on Syncope of Uncertain Etiology (ISSUE) Investigators. Mechanism of syncope in patients with isolated syncope and in patients with tilt-positive syncope","volume":"104","author":"Moya","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.pcad.2012.11.007_bb0240","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/j.jacc.2005.09.043","article-title":"An implantable loop recorder study of highly symptomatic vasovagal patients: the heart rhythm observed during a spontaneous syncope is identical to the recurrent syncope but not correlated with the head-up tilt test or adenosine triphosphate test","volume":"47","author":"Deharo","year":"2006","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.pcad.2012.11.007_bb0245","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1161\/CIRCULATIONAHA.111.022855","article-title":"Treatment of unexplained syncope: a multicenter, randomized trial of cardiac pacing guided by adenosine 5'-triphosphate testing","volume":"125","author":"Flammang","year":"2012","journal-title":"Circulation"},{"key":"10.1016\/j.pcad.2012.11.007_bb0250","doi-asserted-by":"crossref","first-page":"2566","DOI":"10.1161\/CIRCULATIONAHA.111.082313","article-title":"Pacemaker therapy in patients with neurally mediated syncope and documented asystole: Third International Study on Syncope of Uncertain Etiology (ISSUE-3): a randomized trial","volume":"125","author":"Brignole","year":"2012","journal-title":"Circulation"},{"key":"10.1016\/j.pcad.2012.11.007_bb0255","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1056\/NEJM198207153070301","article-title":"Natural history of high risk bundle branch block: final report of a prospective study","volume":"307","author":"McAnulty","year":"1982","journal-title":"N Engl J Med"},{"key":"10.1016\/j.pcad.2012.11.007_bb0260","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.1161\/hc4201.097837","article-title":"Mechanism of syncope in patients with bundle branch block and negative electrophysiological test","volume":"104","author":"Brignole","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.pcad.2012.11.007_bb0265","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1016\/j.jacc.2007.11.065","article-title":"Syncope predicts the outcome of cardiomyopathy patients: analysis of the SCD-HeFT study","volume":"51","author":"Olshansky","year":"2008","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.pcad.2012.11.007_bb0270","doi-asserted-by":"crossref","first-page":"2256","DOI":"10.1093\/eurheartj\/ehm305","article-title":"European Society of Cardiology; European Heart Rhythm Association. Guidelines for cardiac pacing and cardiac resynchronization therapy","volume":"28","author":"Vardas","year":"2007","journal-title":"Eur Heart J"},{"key":"10.1016\/j.pcad.2012.11.007_bb0275","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1093\/eurheartj\/ehr071","article-title":"Diagnosis, management, and outcomes of patients with syncope and bundle branch block on behalf of the Bradycardia detection in Bundle Branch Block (B4) study","volume":"32","author":"Moya","year":"2011","journal-title":"Eur Heart J"},{"key":"10.1016\/j.pcad.2012.11.007_bb0280","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1093\/europace\/eus005","article-title":"Empiric pacemaker compared with a monitoring strategy in patients with syncope and bifascicular conduction block\u2014rationale and design of the Syncope: Pacing or Recording in ThE Later Years (SPRITELY) study","volume":"14","author":"Krahn","year":"2012","journal-title":"Europace"}],"container-title":["Progress in Cardiovascular Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0033062012002149?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0033062012002149?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,17]],"date-time":"2018-10-17T21:51:20Z","timestamp":1539813080000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0033062012002149"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,1]]},"references-count":56,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2013,1]]}},"alternative-id":["S0033062012002149"],"URL":"https:\/\/doi.org\/10.1016\/j.pcad.2012.11.007","relation":{},"ISSN":["0033-0620"],"issn-type":[{"value":"0033-0620","type":"print"}],"subject":[],"published":{"date-parts":[[2013,1]]}}}